Anti-oxidative stress action

Anti-oxidative stress action is a pharmacological or physiological process characterized by the neutralization of reactive oxygen species (ROS) and the mitigation of oxidative damage to cellular structures, including DNA, proteins, and lipids (PMID: 25923507). This term does not refer to a single molecular target like a specific receptor or enzyme, but rather describes a collective biological effect or therapeutic outcome produced by various agents (PMID: 22442436). The primary orchestrator of this action at a cellular level is the NRF2 transcription factor, which regulates a wide array of antioxidant and phase II detoxification genes in response to oxidative challenge (PMID: 2724665). Chronic oxidative stress is a fundamental driver of pathology in diseases such as Parkinson's, Alzheimer's, atherosclerosis, and chronic inflammation, making the induction of anti-oxidative stress action a key goal in drug development (PMID: 21151605). While therapeutic strategies like NRF2 activators or ROS scavengers offer tissue protection, clinical application remains challenging due to the dual role of ROS as essential signaling molecules in normal physiology. Over-suppression of these species can lead to impaired immune responses or the unintended survival of malignant cells (PubChem).

Other names

Antioxidant activityReduction of oxidative stressReactive oxygen species scavengingRedox modulationCellular antioxidant response

Anti-oxidative stress action is achieved through two primary mechanisms: the direct chemical neutralization (scavenging) of reactive oxygen species (ROS) or the indirect activation of endogenous antioxidant defense systems, most notably the NRF2/ARE signaling pathway. Activation of the transcription factor Nuclear factor erythroid 2-related factor 2 (NRF2) leads to the up-regulation of protective enzymes such as superoxide dismutase (SOD), catalase, and glutathione peroxidase, which together restore cellular redox balance (PMID: 22442436, PMID: 2724665).